Krystal Biotech, Inc. (KRYS)
274.21
+10.15
(+3.84%)
USD |
NASDAQ |
Apr 17, 16:00
274.42
+0.21
(+0.08%)
After-Hours: 20:00
Krystal Biotech SG&A Expense (Quarterly) : 41.45M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Scholar Rock Holding Corp. | 45.02M |
| Stoke Therapeutics, Inc. | 21.15M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| TG Therapeutics, Inc. | 62.74M |